Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-11-23 08:51 |
Pharming Group announces presentation of new leniolisib data at 2022 ASH Annual…
|
English | 220.2 KB | ||
| 2022-11-02 09:28 |
Pharming to present at Stifel Healthcare Conference
|
English | 165.0 KB | ||
| 2022-11-02 09:28 |
Pharming to present at Stifel Healthcare Conference
|
English | 199.5 KB | ||
| 2022-10-28 07:03 |
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Auth…
|
Dutch | 265.4 KB | ||
| 2022-10-28 07:03 |
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Auth…
|
English | 285.6 KB | ||
| 2022-10-27 07:42 |
Pharming Group reports earnings for the first nine months of 2022
|
Dutch | 472.1 KB | ||
| 2022-10-27 07:42 |
Pharming Group reports earnings for the first nine months of 2022
|
English | 435.2 KB | ||
| 2022-10-11 07:44 |
Pharming submits a Marketing Authorisation Application to the European Medicine…
|
English | 254.9 KB | ||
| 2022-10-11 07:44 |
Pharming submits a Marketing Authorisation Application to the European Medicine…
|
English | 243.1 KB | ||
| 2022-09-28 09:00 |
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Applic…
|
Dutch | 319.4 KB | ||
| 2022-09-28 09:00 |
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Applic…
|
English | 280.4 KB | ||
| 2022-09-23 10:45 | English | 509.4 KB | |||
| 2022-08-04 08:10 |
Pharming Group reports financial results for the first half of 2022
|
English | 761.4 KB | ||
| 2022-08-04 08:10 |
Pharming Group reports financial results for the first half of 2022
|
English | 739.8 KB | ||
| 2022-08-02 08:01 |
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
|
English | 145.6 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
